Literature DB >> 22205689

Molecular pathways: involvement of Helicobacter pylori-triggered inflammation in the formation of an epigenetic field defect, and its usefulness as cancer risk and exposure markers.

Toshikazu Ushijima1, Naoko Hattori.   

Abstract

Infection-associated cancers account for a large proportion of human cancers, and gastric cancer, the vast majority of which is associated with Helicobacter pylori infection, is a typical example of such cancers. Epigenetic alterations are known to occur frequently in gastric cancers, and H. pylori infection has now been shown to induce aberrant DNA methylation in gastric mucosae. Accumulation of aberrant methylation in gastric mucosae produces a field for cancerization, and methylation levels correlate with gastric cancer risk. H. pylori infection induces methylation of specific genes, and such specificity is determined by the epigenetic status in normal cells, including the presence of H3K27me3 and RNA polymerase II (active or stalled). Specific types of inflammation, such as that induced by H. pylori infection, are important for methylation induction, and infiltration of monocytes appears to be involved. The presence of an epigenetic field defect is not limited to gastric cancers and is observed in various types of cancers. It provides translational opportunities for cancer risk diagnosis incorporating life history, assessment of past exposure to carcinogenic factors, and cancer prevention. ©2011 AACR.

Entities:  

Mesh:

Year:  2011        PMID: 22205689     DOI: 10.1158/1078-0432.CCR-11-2011

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  51 in total

Review 1.  Influence of bacteria on epigenetic gene control.

Authors:  Kyoko Takahashi
Journal:  Cell Mol Life Sci       Date:  2013-10-15       Impact factor: 9.261

Review 2.  The wayward methyl group and the cascade to cancer.

Authors:  Robert M Hoffman
Journal:  Cell Cycle       Date:  2017-03-20       Impact factor: 4.534

Review 3.  Epigenetics and bacterial infections.

Authors:  Hélène Bierne; Mélanie Hamon; Pascale Cossart
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

4.  Editorial: an obsession with subtyping gastric cancer.

Authors:  Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2013-10       Impact factor: 7.370

5.  TET repression and increased DNMT activity synergistically induce aberrant DNA methylation.

Authors:  Hideyuki Takeshima; Tohru Niwa; Satoshi Yamashita; Takeji Takamura-Enya; Naoko Iida; Mika Wakabayashi; Sohachi Nanjo; Masanobu Abe; Toshiro Sugiyama; Young-Joon Kim; Toshikazu Ushijima
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

6.  Novel epigenetic markers for gastric cancer risk stratification in individuals after Helicobacter pylori eradication.

Authors:  Masahiro Maeda; Satoshi Yamashita; Taichi Shimazu; Naoko Iida; Hideyuki Takeshima; Takeshi Nakajima; Ichiro Oda; Sohachi Nanjo; Chika Kusano; Akiko Mori; Hiroshi Moro; Harumi Yamada; Shoichiro Tsugane; Toshiro Sugiyama; Yoshiharu Sakai; Toshikazu Ushijima
Journal:  Gastric Cancer       Date:  2018-02-09       Impact factor: 7.370

Review 7.  An evolutionary perspective on field cancerization.

Authors:  Kit Curtius; Nicholas A Wright; Trevor A Graham
Journal:  Nat Rev Cancer       Date:  2017-12-08       Impact factor: 60.716

8.  Gene copy number gain of EGFR is a poor prognostic biomarker in gastric cancer: evaluation of 855 patients with bright-field dual in situ hybridization (DISH) method.

Authors:  Eiji Higaki; Takeshi Kuwata; Akiko Kawano Nagatsuma; Yasunori Nishida; Takahiro Kinoshita; Masaki Aizawa; Hiroaki Nitta; Masato Nagino; Atsushi Ochiai
Journal:  Gastric Cancer       Date:  2014-12-09       Impact factor: 7.370

9.  Gastric cancer incidence and mortality is associated with altitude in the mountainous regions of Pacific Latin America.

Authors:  Javier Torres; Pelayo Correa; Catterina Ferreccio; Gustavo Hernandez-Suarez; Rolando Herrero; Maria Cavazza-Porro; Ricardo Dominguez; Douglas Morgan
Journal:  Cancer Causes Control       Date:  2012-12-07       Impact factor: 2.506

10.  Advances in gastric cancer prevention.

Authors:  Antonio Giordano; Letizia Cito
Journal:  World J Clin Oncol       Date:  2012-09-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.